Veteran life sciences investor Neil Woodford has put his money where his mouth is by choosing AstraZeneca as the single biggest investment for his new fund.
Mr Woodford has poured 8.2pc of the £1.6bn fund into the FTSE 100 drug maker which recently fended off a £70bn takeover attempt by its US rival Pfizer.
Help employers find you! Check out all the jobs and post your resume.
